// App-Quantinova.ai

2265 : Identification of Molecular Mechanisms Responsible for the Development of Extramedullary Disease in Myeloma and Potential Novel Therapeutic Targets Using Transcriptomic and Exome Profiling

Researchers

Presenter

  • David Zihala

Principal Investigators

  • Tereza Sevcikova

  • Michal Simicek

  • Tereza Popkova

  • Hana Plonkova

  • Lucie Broskevicova

  • Jan Vrana

  • Juli R. Bago

  • Roman Hajek

  • Giovanni Stracquadanio

  • Tomas Jelinek

Medical Centers

  • Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

  • Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic

  • Department of Biology and Ecology,University of Ostrava,Ostrava,Czech Republic

  • Institute of Quantitative Biology, Biochemistry, and Biotechnology, SynthSys, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom

Locations

  • Czech Republic

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved